Actis Biologics Private Limited
About Actis Biologics Private Limited
Data last updated:
Actis Biologics Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 27 December 2005.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC158347.
The company has an authorised share capital of ₹6.15 Cr and a paid-up capital of ₹5.4 Cr. It is led by directors Sanjeev Kirpachandra Saxena and Savita Saxena.
Its last annual general meeting (AGM) was held on 13 December 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office is at 201 Vedanta Makwana Road Off Andheri – Kurla Road Marol Andheri (East), Mumbai, Maharashtra, India – 400049.
As per MCA filings, the company has open charges of ₹11.77 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 1 case is pending.
Company details
Contact details
Actis Biologics Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address201 Vedanta Makwana Road Off Andheri – Kurla Road Marol Andheri (East), Mumbai, Maharashtra, India – 400049
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Actis Biologics Private Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Actis Biologics Private Limited, buy the company report.
Board of directors of Actis Biologics Private Limited
Actis Biologics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Kirpachandra Saxena | Director | 27 Dec 2005 | 20 Years 10 Months | As last reported |
| Savita Saxena | Director | 27 Dec 2005 | 20 Years 10 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jul 2009 | 10168624 | Department of Biotechnology | ₹2.73 Cr | Open | |
| 10 Jul 2008 | 10131783 | Phoenix Arc Private Limited | ₹9.05 Cr | Open |
To see the full charge records of Actis Biologics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Actis Biologics Private Limited has 6 court cases on record: 6 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Company petition | Filed against the company by Icici Bank Limited | Disposed |
| District court, Raigad, Maharashtra | Court case (Review Appln.) | Filed against the company by Innovassynth Technologies India Limited Through Anil Bahuguni | Pending |
| District court, Raigad, Maharashtra | Court case (R.C.C.) | Filed against the company by Phonex Arc Pvt. Limited | Disposed |
| Bombay High Court | Court case (OLR) | Filed against the company by The Official Liquidator High Court Bombay | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP1) | Filed against the company by an individual | Disposed |
To see the full case history of Actis Biologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Actis Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Actis Biologics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Actis Biologics Private Limited has 5 board changes on record since 2005: 2 appointments and 3 cessations. The latest: Dhiren Bhogilal Kothary ceased to be Director on 12 Jun 2010.
Frequently asked questions
Actis Biologics is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Actis Biologics is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 27 December 2005 and is registered under CIN U24230MH2005PTC158347. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Actis Biologics has 2 current directors:
- Sanjeev Kirpachandra Saxena - Director
- Savita Saxena - Director
The latest financial statements of Actis Biologics on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 13 December 2010. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Actis Biologics is U24230MH2005PTC158347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actis Biologics has open charges of ₹11.77 Cr and no satisfied charges on record as per latest MCA filings.
Actis Biologics has 6 court cases on record: 6 filed against it. 1 is pending. Most are in the district courts.
Actis Biologics was incorporated on 27 December 2005. It is registered with the Registrar of Companies, Mumbai.
Dhiren Bhogilal Kothary ceased to be Director on 12 Jun 2010. Mukund Dharamdas Dalal ceased to be Director on 12 Jun 2010. Sudhir Bhagawant Karnik ceased to be Alternate Director on 25 Jun 2008. Actis Biologics has 5 board changes on record in total.
The registered office of Actis Biologics is at 201 Vedanta Makwana Road Off Andheri – Kurla Road Marol Andheri East, Mumbai, Maharashtra, India – 400049.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
